Randomised, double-blind, placebo-controlled study to assess long-term effect of dupilumab on prevention of lung function decline (LFD) in patients with uncontrolled moderate-to-severe asthma: ATLAS trial

被引：0
|
作者：
Gomez, L. De Prado [1 ]
Pavord, I. [2 ]
Busse, W. [3 ]
Brightling, C. E. [4 ]
Wechsler, M. E. [5 ]
Rabe, K. F. [6 ,7 ,8 ]
Zhang, M. [9 ]
Xing, J. [9 ]
Jacob-Nara, J. A. [9 ]
Rowe, P. J. [9 ]
机构：
[1] Sanofi, Reading, Berks, England
[2] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
[3] Univ Wisconsin, UW Allergy Pulm & Crit Care Med, Sch Med & Publ Hlth, Madison, WI USA
[4] Univ Leicester, Inst Lung Hlth, Dept Resp Sci, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England
[5] Natl Jewish Hlth, Denver, CO USA
[6] LungenClin Grosshansdorf, Grosshansdorf, Germany
[7] German Ctr Lung Res DZL, ARCN, Grosshansdorf, Germany
[8] Univ Kiel, ARCN, German Ctr Lung Res DZL, Kiel, Germany
[9] Sanofi, Bridgewater, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2288
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2288
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study
    Maspero, Jorge F.
    Peters, Anju T.
    Chapman, Kenneth R.
    Domingo, Christian
    Stewart, John
    Hardin, Megan
    Maroni, Jaman
    Tawo, Kelsey
    Khokhar, Faisal A.
    Mortensen, Eric
    Laws, Elizabeth
    Radwan, Amr
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (04): : 991 - 997.e6
  • [32] Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
    Ferguson, Gary T.
    FitzGerald, J. Mark
    Bleecker, Eugene R.
    Laviolette, Michel
    Bernstein, David
    LaForce, Craig
    Mansfield, Lyndon
    Barker, Peter
    Wu, Yanping
    Jison, Maria
    Goldman, Mitchell
    LANCET RESPIRATORY MEDICINE, 2017, 5 (07): : 568 - 576
  • [33] Long-term treatment effect of dupilumab on lung function in pediatric patients with uncontrolled asthma
    Bacharier, L. B.
    Guilbert, T. W.
    Custovic, A.
    Altincatal, A.
    Ledanois, O.
    Gall, R.
    Sacks, H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    ALLERGOLOGIE, 2023, 46 (08) : 545 - 545
  • [34] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Tyring, Stephen K. K.
    Rich, Phoebe
    Tada, Yayoi
    Beeck, Stefan
    Messina, Izabella
    Liu, Jie
    Huang, Xiaohong
    Shumack, Stephen
    DERMATOLOGY AND THERAPY, 2023, 13 (02) : 595 - 608
  • [35] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Stephen K. Tyring
    Phoebe Rich
    Yayoi Tada
    Stefan Beeck
    Izabella Messina
    Jie Liu
    Xiaohong Huang
    Stephen Shumack
    Dermatology and Therapy, 2023, 13 : 595 - 608
  • [36] A double-blind, placebo-controlled, crossover trial to assess the efficacy and safety of infliximab for patients with moderate to severe hidradenitis suppurativa
    Grant, Annika
    Gonzalez, T.
    Kerdel, E. A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB38 - AB38
  • [37] Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study
    Amidfar, M.
    Khiabany, M.
    Kohi, A.
    Salardini, E.
    Arbabi, M.
    Azizi, M. Roohi
    Zarrindast, M. -R.
    Mohammadinejad, P.
    Zeinoddini, A.
    Akhondzadeh, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (01) : 44 - 50
  • [38] EFFECT OF LEUPROLIDE ACETATE (LA) IN PATIENTS WITH MODERATE-TO-SEVERE FUNCTIONAL BOWEL-DISEASE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    MATHIAS, JR
    CLENCH, MH
    REEVESDARBY, VG
    ROBERTS, PH
    SMITH, LL
    GASTROENTEROLOGY, 1993, 104 (04) : A548 - A548
  • [39] Long-term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: The Liberty Asthma Traverse Continuation Study
    Maspero, J. F.
    Peters, A.
    Chapman, K. R.
    Domingo, C.
    Stewart, J.
    Hardin, M.
    Maroni, J.
    Tawo, K.
    Khokhar, F. A.
    Mortensen, E.
    Laws, E.
    Radwan, A.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [40] Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia
    Kane, J. M.
    Mackle, M.
    Snow-Adami, L.
    Zhao, J.
    Szegedi, A.
    Panagides, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 223 - 223
12345